These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18889215)

  • 1. A chemical analysis of the phospholipids of the brain in disseminated sclerosis.
    WEIL A
    J Neuropathol Exp Neurol; 1948 Oct; 7(4):453-6. PubMed ID: 18889215
    [No Abstract]   [Full Text] [Related]  

  • 2. A chemical analysis of phospholipids of the brain in disseminated sclerosis.
    WEIL A
    Trans Am Neurol Assoc; 1948; 73(73 Annual Meet.):232. PubMed ID: 18111304
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations of phospholipids, particularly plasmalogens, in the demyelination of multiple sclerosis as compared with that of cerebral oedema.
    Yanagihara T; Cumings JN
    Brain; 1969 Mar; 92(1):59-70. PubMed ID: 5774032
    [No Abstract]   [Full Text] [Related]  

  • 4. Phospholipids in demyelinating diseases.
    Bukovský V; Dobrota D; Mézesová V
    Acta Univ Carol Med (Praha); 1987; 33(7-8):561-9. PubMed ID: 3455640
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glycerophosphatides and sphingolipids in normal white matter of multiple sclerosis brains (author's transl)].
    Woelk H; Borri P
    Z Neurol; 1973 Nov; 205(3):243-56. PubMed ID: 4129049
    [No Abstract]   [Full Text] [Related]  

  • 6. [On changes of some fatty acids with 18 carbon atoms in demyelination plaques in multiple sclerosis. Their significance in the mechanisms of demyelination].
    Amaducci L; Pazzagli A
    Riv Patol Nerv Ment; 1966 Aug; 87(4):329-50. PubMed ID: 5988024
    [No Abstract]   [Full Text] [Related]  

  • 7. [RESULTS OF CHEMICAL ANALYSIS OF BRAIN TISSUE IN DEMYELINATION DISEASES].
    WENDER M; WALIGORA Z
    Psychiatr Neurol Med Psychol (Leipz); 1964 Aug; 16():299-303. PubMed ID: 14301239
    [No Abstract]   [Full Text] [Related]  

  • 8. [PROTEINS AND LIPIDS IN PLAQUES OF DEMYELINATION IN MULTIPLE SCLEROSIS].
    AMADUCCI L; PAZAGLI A
    Riv Patol Nerv Ment; 1963 Jun; 84():169-80. PubMed ID: 14088040
    [No Abstract]   [Full Text] [Related]  

  • 9. SOME LIPID DISEASES OF THE BRAIN.
    CUMINGS JN
    Proc R Soc Med; 1965 Jan; 58(1):21-8. PubMed ID: 14267494
    [No Abstract]   [Full Text] [Related]  

  • 10. [RESEARCH ON THE INDICES OF CURRENT BIOLOGICAL FLUCTUATION IN MULTIPLE SCLEROSIS. FLUCTUATION OF THE PLASMA PHOSPHOLIPID FRACTIONS IN MULTIPLE SCLEROSIS].
    KETELAER CJ; DELMOTTE P
    Acta Neurol Psychiatr Belg; 1965 Jan; 65():35-56. PubMed ID: 14298781
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility-weighted imaging helps to discriminate pediatric multiple sclerosis from acute disseminated encephalomyelitis.
    Kelly JE; Mar S; D'Angelo G; Zhou G; Rajderkar D; Benzinger TL
    Pediatr Neurol; 2015 Jan; 52(1):36-41. PubMed ID: 25532777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISCHAEMIC LEUCOENCEPHALOPATHY. A CASE PRESENTING WITH PRESENILE DEMENTIA.
    MANI KS; MCMENEMEY WH; CUMINGS JN
    Confin Neurol; 1964; 24():404-16. PubMed ID: 14222217
    [No Abstract]   [Full Text] [Related]  

  • 13. [A transitory form of disseminated and diffuse sclerosis of the brain].
    OSETOWSKA E; ZELMAN I; MOSSAKOWSKI M
    Patol Pol; 1961; 12():381-90. PubMed ID: 14482487
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of disseminated sclerosis and glioma of the brain in the same patient.
    MUNCH-PETERSEN CJ
    Acta Psychiatr Neurol; 1949; 24(3-4):599-605. PubMed ID: 15390925
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffuse-disseminated sclerosis combined with partial arylsulfatase A (ASA) deficiency. Mixed heterozygosity of ASA- and pseudo-ASA-deficiency?
    Peiffer J; Harzer K; Schlote W
    Neuropediatrics; 1984 May; 15(2):59-62. PubMed ID: 6146104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon assay of multiple sclerosis tissue.
    Sibley WA; Tourtellotte WW
    Trans Am Neurol Assoc; 1968; 93():124-7. PubMed ID: 5711004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Familial cases of disseminated sclerosis].
    Markova ED; Gurskaia NZ; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(6):837-41. PubMed ID: 899487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent protein tracing in multiple sclerosis brain tissue.
    Simpson JF; Tourtellotte WW; Kokmen E; Parker JA
    Neurology; 1968 Mar; 18(3):295. PubMed ID: 4172884
    [No Abstract]   [Full Text] [Related]  

  • 19. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?
    Stadelmann C; Kerschensteiner M; Misgeld T; Brück W; Hohlfeld R; Lassmann H
    Brain; 2002 Jan; 125(Pt 1):75-85. PubMed ID: 11834594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmortem evaluation of the blood-brain barrier in multiple sclerosis.
    Tourtellotte WW; Parker JA
    J Neuropathol Exp Neurol; 1968 Jan; 27(1):159-63. PubMed ID: 5656574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.